|
Jan 9
|
Final Boarding Call: 3 Stocks Set for a Sky-High Surge
|
|
Jan 8
|
ORIC Pharmaceuticals Provides Initial Phase 1b Data for ORIC-944, Operational Highlights for 2023, and Anticipated Upcoming Milestones
|
|
Nov 6
|
ORIC Pharmaceuticals Inc (ORIC) Reports Q3 2023 Financial Results and Operational Updates
|
|
Nov 6
|
ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
|
|
Nov 4
|
Here's Why We're Not Too Worried About ORIC Pharmaceuticals' (NASDAQ:ORIC) Cash Burn Situation
|
|
Nov 3
|
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
|
Nov 2
|
ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC-533 in Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting
|